Stock analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Can TikTok Stock Picks Really Make You Rich?
- Profitably Trade Stocks at 52-Week Highs
- The “Quality” Rotation: Back to Basics Investing
- How Technical Indicators Can Help You Find Oversold Stocks
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.